Investment Premium

This week’s family/private investment office deals

by

Post-IPO Equity Aquilo Capital Management, an investment group owned by US investor Marc Schneidman, has invested in Pieris Pharmaceuticals. Aquilo was one of five investors committing $32 million to the […]

This is a Premium article. Please subscribe to continue reading.

Leave a Reply

Your email address will not be published. Required fields are marked *